These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 18461063)

  • 41. Commentary. Transition from primary Raynaud's phenomenon to secondary Raynaud's phenomenon identified by diagnosis of an associated disease. Results of ten years of prospective surveillance.
    Moneta GL
    Perspect Vasc Surg Endovasc Ther; 2007 Sep; 19(3):341-2. PubMed ID: 17911571
    [No Abstract]   [Full Text] [Related]  

  • 42. Digital necrosis as an early manifestation of limited cutaneous systemic sclerosis.
    J Clin Rheumatol; 1997 Dec; 3(6):376-7. PubMed ID: 19078231
    [No Abstract]   [Full Text] [Related]  

  • 43. Efficacy of sildenafil on ischaemic digital ulcer healing in systemic sclerosis: the placebo-controlled SEDUCE study.
    Hachulla E; Hatron PY; Carpentier P; Agard C; Chatelus E; Jego P; Mouthon L; Queyrel V; Fauchais AL; Michon-Pasturel U; Jaussaud R; Mathian A; Granel B; Diot E; Farge-Bancel D; Mekinian A; Avouac J; Desmurs-Clavel H; Clerson P;
    Ann Rheum Dis; 2016 Jun; 75(6):1009-15. PubMed ID: 25995322
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy of Raynaud's phenomenon and digital ulcer pharmacological treatment in systemic sclerosis patients: a systematic literature review.
    García de la Peña Lefebvre P; Nishishinya MB; Pereda CA; Loza E; Sifuentes Giraldo WA; Román Ivorra JA; Carreira P; Rúa-Figueroa I; Pego-Reigosa JM; Muñoz-Fernández S
    Rheumatol Int; 2015 Sep; 35(9):1447-59. PubMed ID: 25824427
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Points to consider for skin ulcers in systemic sclerosis.
    Galluccio F; Allanore Y; Czirjak L; Furst DE; Khanna D; Matucci-Cerinic M
    Rheumatology (Oxford); 2017 Sep; 56(suppl_5):v67-v71. PubMed ID: 28992171
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Registry evaluation of digital ulcers in systemic sclerosis.
    Galluccio F; Matucci-Cerinic M
    Int J Rheumatol; 2010; 2010():. PubMed ID: 20862203
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Therapeutic management of acral manifestations of systemic sclerosis].
    Meyer MF; Daigeler A; Lehnhardt M; Steinau HU; Klein HH
    Med Klin (Munich); 2007 Mar; 102(3):209-18. PubMed ID: 17345017
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevention of vascular damage in scleroderma and autoimmune Raynaud's phenomenon: a multicenter, randomized, double-blind, placebo-controlled trial of the angiotensin-converting enzyme inhibitor quinapril.
    Gliddon AE; Doré CJ; Black CM; McHugh N; Moots R; Denton CP; Herrick A; Barnes T; Camilleri J; Chakravarty K; Emery P; Griffiths B; Hopkinson ND; Hickling P; Lanyon P; Laversuch C; Lawson T; Mallya R; Nisar M; Rhys-Dillon C; Sheeran T; Maddison PJ
    Arthritis Rheum; 2007 Nov; 56(11):3837-46. PubMed ID: 17968938
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Statins: potentially useful in therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers.
    Abou-Raya A; Abou-Raya S; Helmii M
    J Rheumatol; 2008 Sep; 35(9):1801-8. PubMed ID: 18709692
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MQX-503, a novel formulation of nitroglycerin, improves the severity of Raynaud's phenomenon: a randomized, controlled trial.
    Chung L; Shapiro L; Fiorentino D; Baron M; Shanahan J; Sule S; Hsu V; Rothfield N; Steen V; Martin RW; Smith E; Mayes M; Simms R; Pope J; Kahaleh B; Csuka ME; Gruber B; Collier D; Sweiss N; Gilbert A; Dechow FJ; Gregory J; Wigley FM
    Arthritis Rheum; 2009 Mar; 60(3):870-7. PubMed ID: 19248104
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oxymorphone extended release for the treatment of chronic low back pain: a retrospective pooled analysis of enriched-enrollment clinical trial data stratified according to age, sex, and prior opioid use.
    Peniston JH; Gould E
    Clin Ther; 2009 Feb; 31(2):347-59. PubMed ID: 19302907
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of clonazepam on Raynaud's phenomenon and fingertip ulcers in scleroderma.
    Colakoğlu M; Cobankara V; Akpolat T
    Ann Pharmacother; 2007 Sep; 41(9):1544-7. PubMed ID: 17666574
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lack of efficacy of quinapril on vascular damage in limited cutaneous systemic sclerosis.
    Guiducci S; Cerinic MM
    Nat Clin Pract Rheumatol; 2008 Jun; 4(6):288-9. PubMed ID: 18461063
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Treatments of progressive systemic sclerosis].
    Vayssairat M; Abdoucheli-Baudot N; Gaitz JP
    J Mal Vasc; 2001 Oct; 26(4):258-61. PubMed ID: 11679856
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.